IgG-like bispecific antibodies with potent and synergistic neutralization against circulating SARS-CoV-2 variants of concern
Por um escritor misterioso
Descrição
![IgG-like bispecific antibodies with potent and synergistic neutralization against circulating SARS-CoV-2 variants of concern](https://www.embopress.org/cms/asset/58f2bb52-19e9-4511-a7c3-37846257141d/embr202154199-fig-0001-m.png)
Biparatopic sybodies neutralize SARS‐CoV‐2 variants of concern and mitigate drug resistance
![IgG-like bispecific antibodies with potent and synergistic neutralization against circulating SARS-CoV-2 variants of concern](https://d2jx2rerrg6sh3.cloudfront.net/image-handler/picture/2021/6/shutterstock_1700532739_(2).jpg)
Multivalent antibodies show high potency against SARS-CoV-2 in new study
![IgG-like bispecific antibodies with potent and synergistic neutralization against circulating SARS-CoV-2 variants of concern](https://www.science.org/cms/10.1126/scitranslmed.abj5413/asset/c2324a27-de28-47c9-b9e4-214f4121bddc/assets/images/large/scitranslmed.abj5413-f6.jpg)
Bispecific antibodies targeting distinct regions of the spike protein potently neutralize SARS-CoV-2 variants of concern
![IgG-like bispecific antibodies with potent and synergistic neutralization against circulating SARS-CoV-2 variants of concern](https://media.springernature.com/m685/springer-static/image/art%3A10.1007%2Fs40259-022-00529-7/MediaObjects/40259_2022_529_Fig11_HTML.png)
Passive Immunotherapy Against SARS-CoV-2: From Plasma-Based Therapy to Single Potent Antibodies in the Race to Stay Ahead of the Variants
![IgG-like bispecific antibodies with potent and synergistic neutralization against circulating SARS-CoV-2 variants of concern](https://ars.els-cdn.com/content/image/1-s2.0-S258900422300617X-fx1.jpg)
Bispecific antibodies combine breadth, potency, and avidity of parental antibodies to neutralize sarbecoviruses - ScienceDirect
![IgG-like bispecific antibodies with potent and synergistic neutralization against circulating SARS-CoV-2 variants of concern](https://www.thelancet.com/cms/attachment/9ff97a2b-efe5-418b-82f6-09b7dd8f1bc0/gr3.jpg)
Monoclonal antibodies targeting two immunodominant epitopes on the Spike protein neutralize emerging SARS-CoV-2 variants of concern - eBioMedicine
![IgG-like bispecific antibodies with potent and synergistic neutralization against circulating SARS-CoV-2 variants of concern](https://www.biorxiv.org/content/biorxiv/early/2023/10/27/2023.10.26.564289/F1.large.jpg)
Overcoming antibody-resistant SARS-CoV-2 variants with bispecific antibodies constructed using non-neutralizing antibodies
![IgG-like bispecific antibodies with potent and synergistic neutralization against circulating SARS-CoV-2 variants of concern](https://www.pnas.org/cms/10.1073/pnas.2314193120/asset/a0e89179-d734-49b2-af6d-dbbfc90ed4b7/assets/images/large/pnas.2314193120fig05.jpg)
Defining a de novo non-RBM antibody as RBD-8 and its synergistic rescue of immune-evaded antibodies to neutralize Omicron SARS-CoV-2
![IgG-like bispecific antibodies with potent and synergistic neutralization against circulating SARS-CoV-2 variants of concern](https://www.mdpi.com/antibodies/antibodies-12-00005/article_deploy/html/images/antibodies-12-00005-g002.png)
Antibodies, Free Full-Text
![IgG-like bispecific antibodies with potent and synergistic neutralization against circulating SARS-CoV-2 variants of concern](https://www.cell.com/cms/attachment/2110543095/2083223270/fx1.jpg)
Engineered Bispecific Antibodies with Exquisite HIV-1-Neutralizing Activity: Cell
![IgG-like bispecific antibodies with potent and synergistic neutralization against circulating SARS-CoV-2 variants of concern](https://www.science.org/cms/10.1126/sciimmunol.ade0958/asset/0dde0d90-22fa-4177-8ae0-d7d4e8633ee9/assets/images/large/sciimmunol.ade0958-f1.jpg)
Human neutralizing antibodies to cold linear epitopes and subdomain 1 of the SARS-CoV-2 spike glycoprotein
![IgG-like bispecific antibodies with potent and synergistic neutralization against circulating SARS-CoV-2 variants of concern](https://www.science.org/cms/10.1126/scitranslmed.abj5413/asset/4a6f8f84-e449-4f44-8d57-537ad97ac2dc/assets/images/large/scitranslmed.abj5413-f7.jpg)
Bispecific antibodies targeting distinct regions of the spike protein potently neutralize SARS-CoV-2 variants of concern
de
por adulto (o preço varia de acordo com o tamanho do grupo)